Recent Updates
Recently added Catalysts
KMTS Positive Sentiment

Kestra Medical Technologies to Report Third Quarter Fiscal 2026 Financial Results on March 17

Tuesday, March 3, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Kestra Medical Technologies, a prominent player in wearable medical devices, will report its third quarter fiscal 2026 financial results on March 17. A conference call is scheduled for 4:30 p.m. ET, allowing investors to engage with management. The company focuses on improving patient outcomes in cardiovascular disease.
Price reaction · baseline $22.75 (2026-03-02 close) · hit pre-market · clean, no other KMTS news in the window
day 0 close
+0.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Kestra Medical Technologies is a leading company in wearable medical devices.
  • The upcoming financial results indicate ongoing business activity and transparency.
  • Management is engaging with investors through a conference call.

Full Press Release Details

KIRKLAND, Wash., March 03, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it will report third quarter fiscal 2026 financial results on Tuesday, March 17. Management will host a corresponding conference call at 4:30 p.m. Eastern Time.
A live and archived webcast of the conference call will be available in the “Events” section of the investor relationswebsite. Participants are encouraged to register on the website 10 minutes prior to the start of the conference call.
About KestraKestra Medical Technologies, Ltd. is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visitwww.kestramedical.com.

Frequently Asked Questions

When will Kestra Medical report its Q3 2026 results?

Kestra Medical Technologies will report its Q3 2026 financial results on March 17.

What time is the conference call for Q3 results?

The conference call for Q3 results is scheduled for 4:30 p.m. Eastern Time.

How can I access the conference call?

The conference call can be accessed via a live and archived webcast on the investor relations website.

What is Kestra Medical Technologies focused on?

Kestra Medical Technologies focuses on transforming patient outcomes in cardiovascular disease.

ShareAdd on Google
Tags: KMTS Viatris Investor Conferences Healthcare Kestra Medical Technologies wearable medical devices financial results conference call
Last updated: Mar 3, 2026

Biotech snapshot

Cash runway
$196M liquidity · $6M/mo burn
~30 mo
Minimal dilution risk